Sharemaestro Newsreel

LABCORP HOLDINGS 2026: Revenue $3.73B, EPS $3.64— 10-Q Summary

Labcorp Holdings (LH) reported strong second-quarter 2026 results, with revenue reaching $3.73 billion and diluted EPS of $3.64. The company experienced a 5.8% year-over-year revenue growth due to increased test utilization, price/mix gains, and margin expansion. Labcorp also highlighted increased capital spending and strategic …

Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market

Shares of Thermo Fisher Scientific Inc. (TMO) rose 2.32% on Wednesday, closing at $577.83, and outperforming the broader market. The increase broke a three-day losing streak for the stock. This occurred during a mixed trading session where the Dow Jones Industrial Average gained 0.49% …

Twist Bioscience (NASDAQ: TWST) COO sells 2,888 shares for tax withholding

Patrick John Finn, President and COO of Twist Bioscience (NASDAQ: TWST), sold 2,888 shares of common stock on August 3, 2026, at an average price of $85.3212 per share. This transaction was a mandatory "sell to cover" to satisfy tax withholding obligations related to …

Twist Bioscience TWST Rallies As Guidance And Capital Raise Reset The Bar

Twist Bioscience (TWST) experienced a significant stock rally of 16.14% following positive Q3 results, robust Q4 and FY26 guidance, and a $300M equity offering. The company beat revenue expectations, increased its full-year guidance, and is targeting adjusted EBITDA breakeven, signaling an improved path towards …

BIODESIX ($BDSX) Releases Q2 2026 Earnings

Biodesix Inc (NASDAQ:BDSX) is scheduled to release its Q2 2026 earnings on August 5, 2026, with analysts expecting revenue of $26.03 million and earnings of -$0.91 per share. GuruFocus indicates a 6.22% upside based on its GF Value, while analysts have an average target …

Earnings Flash (QGEN) QIAGEN N.V. Reports Q2 Revenue $535.0M, vs. FactSet Est of $527.5M

Earnings Flash (QGEN) QIAGEN N.V. Posts Q2 Adjusted EPS $0.62 per Share, vs. FactSet Est of $0.60

Illumina Inc (ILMN) keeps 44.6% 12-week climb in focus

The diagnostics-and-research stock is drawing heavier activity as trend pressure improves, though Relative Strength remains below leadership territory.

Charles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.28 EPS

Personalis (PSNL) Stock Commands A Premium Despite Deepening Losses

Personalis (PSNL) stock maintains a premium valuation despite reporting deepening losses in Q2 2026, with revenue at US$22.36 million and a net loss of US$31.68 million. While the company has achieved milestones like Medicare coverage for its MRD platform and regulatory wins in the …

[10-Q] LABCORP HOLDINGS INC. Quarterly Earnings Report

LABCORP HOLDINGS INC. (LH) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. The report details the company's financial performance, including revenues of $3,731.1 million for Q2 2026, a 5.8% increase year-over-year, and net earnings attributable to Labcorp …

CRL (CRL) insider files Form 144 for potential 5,046-share sale

An insider at Charles River Laboratories International, Inc. (CRL) has filed a Form 144, indicating a potential sale of up to 5,046 common shares on the NYSE, with an aggregate market value of $1,327,098.00. The shares, which represent a small portion of the 47,738,872 …

Why Revvity (RVTY) Stock Is Up Today

Shares of Revvity (NYSE:RVTY) jumped 3.1% after the life sciences company reported strong second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year guidance. The company announced adjusted EPS of $1.41 on revenue of $729.68 million, driven by 11% organic growth in …

Biodesix Diagnostic Testing Revenue Climbs 42% as Tests Reach 20,900

Biodesix reported strong Q2 2026 results, with total revenue increasing 34% to $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Test volumes grew by 38% to 20,900, contributing to an 82% gross margin. Despite a net loss of $7.3 million, the …

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP

Kirby McInerney LLP has announced an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) for potential securities fraud. This follows Myriad Genetics' report of an 11% year-over-year revenue decline in Q2 2026, reduced full-year guidance, and a significant stock price drop after the announcement. The …

Biodesix (Nasdaq: BDSX) grows Q2 2026 revenue 34% to $26.9M

Biodesix (Nasdaq: BDSX) reported a 34% year-over-year revenue increase in Q2 2026, reaching $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Despite this growth and an improved gross margin of 82%, the company still reported a net loss of $7.3 million …

BIODESIX Inc Q2 2026: Revenue $26.86M, EPS $(0.71) — 10-Q Summary

BIODESIX Inc (BDSX) reported its Q2 2026 results, showing a 34% year-over-year revenue increase to $26.86 million and a narrowed net loss of $7.27 million, or $(0.71) per share, compared to $(1.56) in Q2 2025. The company's diagnostic testing revenue grew by 42%, driven …

Thomas Salice Sells 415 Shares of Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International (NYSE:MTD) Director Thomas Salice sold 415 shares of company stock, reducing his direct stake by 58.7% to 292 shares, for a total of $599,517.30. The company recently reported strong quarterly earnings, beating analyst estimates with $11.46 EPS and $1.03 billion in revenue. …

Labcorp Holdings (LH) Could Be 4% Undervalued As Guidance Rises And New Tests Roll Out

Labcorp Holdings (LH) reported strong Q2 2026 results with US$3,731.1 million in revenue and US$298.7 million in net income, leading to raised full-year guidance and new precision oncology and genetic testing offerings. The company's stock has seen significant gains, and its shares are considered …

IDEXX Laboratories 2026: Revenue $1.22B, EPS $4.27— 10-Q Summary

IDEXX Laboratories reported strong financial results for the quarter ended 2026, with revenue of $1.22 billion and diluted EPS of $4.27, both exceeding the prior year. The growth was driven by higher volumes and prices in core segments, particularly recurring diagnostics and reference lab …

A Look at RadNet Inc (RDNT) After 3.1% Decline -- GF Value $68.2

RadNet Inc (RDNT) shares recently dropped 3.1%, but its GF Value™ indicates a 1.7% undervaluation at $67.06 compared to $68.23. The company has a strong GF Score™ of 82/100, driven by growth and valuation, despite being unprofitable and cash-flow negative. While gurus show positive …

Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (NASDAQ:MEDP) securities. The investigation concerns whether Medpace and its officers/directors engaged in corporate wrongdoing, particularly for investors who purchased shares before April 22, 2025, and still hold …

IQVIA (IQV) Teams Up With Medera To Push Cardiac Gene Therapy Forward

IQVIA Holdings (NYSE:IQV) has announced a new alliance with Medera Inc. to advance cardiac gene therapy and human-based drug discovery by leveraging IQVIA's clinical trial infrastructure and Medera's gene therapy work. This partnership expands IQVIA's presence in gene therapies and innovative drug development, aligning …

Charles River Laboratories Stock Rallies As Analysts Hike Targets

Charles River Laboratories International Inc. (NYSE: CRL) stock rallied by 10.96% following positive institutional demand and analyst upgrades, with several major banks raising their price targets. The company's Q2 2026 earnings release, set for August 5, 2026, is a key near-term catalyst, with traders …

Exagen Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-08-05

Exagen Inc. reported record quarterly revenue of $19.9 million in Q2 2026, driven by increased AVISE test volumes and improved pricing. The company raised its full-year 2026 revenue guidance to $72-$75 million and aims for sustainable adjusted EBITDA breakeven at around $80 million in …

Thomas Salice plans Mettler-Toledo (MTD) stock sale under Form 144

Thomas Salice has filed a Form 144 notice to sell 417 shares of Mettler-Toledo International Inc. common stock, valued at $600,651.01, through Merrill on the NYSE around August 5, 2026. These shares originated from a stock option exercise in 2016. Salice also reported a …

DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down

DaVita (DVA) reported adjusted earnings of $4.02 per share in Q2 2026, surpassing the Zacks Consensus Estimate, with revenues of $3.55 billion also exceeding expectations. Despite beating earnings and revenue forecasts and seeing an increase in U.S. dialysis treatments, the company's stock fell in …

Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised

MGX|Metagenomi Inc|Price:1.215|Chg%:+0.005

Metagenomi Inc (MGX) has a TradingKey Stock Score indicating stable fundamentals and significant growth potential, although its valuation is considered fairly valued within the Biotechnology & Medical Research industry. The company, focused on precision genetic medicine, has seen high institutional ownership and multiple "Buy" …

Mettler-Toledo International Inc. stock underperforms Wednesday when compared to competitors

Mettler-Toledo International Inc. (MTD) stock fell 1.08% to $1,421.52 on Wednesday, marking its second consecutive day of losses. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index declined. The article notes the stock's …

Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains

Shares of Agilent Technologies Inc. (A) rose 1.37% to $141.11 on Wednesday, despite the S&P 500 Index falling, but still underperformed compared to the Dow Jones Industrial Average. The stock closed 11.95% below its 52-week high achieved in November. This performance occurred on a …

Earnings Preview: IMDX to Report Financial Results Post-market on August 10

This article announces that IMDX is scheduled to report its financial results after market close on August 10. The report will provide key insights into the company's performance, which investors and analysts will be watching closely.

Sotera Health earnings loom as investors eye new CEO’s execution By Investing.com

Sotera Health is set to report its second-quarter results, with investors keenly watching the performance under new CEO Alton Shader. Analysts anticipate a 33% increase in profit and an 11% jump in sales from the prior quarter, driven by strong market tailwinds in sterilization …

Stifel raises Revvity stock price target to $110 on earnings beat

Stifel increased its price target for Revvity Inc (NYSE:RVTY) shares to $110 from $100, maintaining a Hold rating after the company reported strong Q2 2026 earnings that exceeded expectations. The beat was partly due to tariff refunds and tax savings, but also organic growth …

Labcorp SVP, Chief Accounting Officer Peter J. Wilkinson disposes of 1,420 shares worth $439,103.37

Peter J. Wilkinson, SVP and Chief Accounting Officer at Labcorp, sold 1,420 shares of the company's stock on August 3rd at approximately $309.23 per share, totaling $439,103.37. Prior to this, Wilkinson exercised 1,338 non-qualified stock options at $209.25 per share. Following these transactions, he …

Mettler-Toledo International (NYSE:MTD) Insider Sells $342,513.60 in Stock

Mettler-Toledo International insider Gerry Keller sold 240 shares of company stock for $342,513.60, reducing his direct ownership by 48.1%. The company recently reported quarterly EPS of $11.46, surpassing analyst estimates, with revenue rising 4.5% year over year to $1.03 billion. Despite positive earnings, analyst …